Compare TIRX & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TIRX | PRME |
|---|---|---|
| Founded | 2010 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6M | 601.1M |
| IPO Year | 2021 | 2022 |
| Metric | TIRX | PRME |
|---|---|---|
| Price | $0.66 | $4.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.31 |
| AVG Volume (30 Days) | 138.8K | ★ 3.7M |
| Earning Date | 08-22-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 158.74 | ★ 647.13 |
| 52 Week Low | $0.60 | $1.11 |
| 52 Week High | $6.45 | $6.94 |
| Indicator | TIRX | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 36.80 | 52.01 |
| Support Level | $0.61 | $3.95 |
| Resistance Level | $1.10 | $4.42 |
| Average True Range (ATR) | 0.14 | 0.30 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 13.90 | 76.72 |
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.